These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23139611)

  • 1. Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis.
    Tokudome K; Funaki Y; Sasaki M; Izawa S; Tamura Y; Iida A; Ogasawara N; Konagaya T; Tokura Y; Kasugai K
    World J Gastroenterol; 2012 Nov; 18(41):5940-7. PubMed ID: 23139611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term comparison of plication configurations for endoluminal gastroplication: circumferential versus helical.
    Davis RE; Iqbal A; Gerhardt JD; Welch RA; Turaga K; Tierney B; Haider M; Filipi CJ
    J Clin Gastroenterol; 2005; 39(10):869-76. PubMed ID: 16208110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoluminal gastroplication for the treatment of gastroesophageal reflux disease: a 2-year prospective pilot study from Taiwan.
    Liao CC; Lee CL; Lin BR; Bai CH; Hsieh YH; Wu CH; Gostout CJ
    J Gastroenterol Hepatol; 2008 Mar; 23(3):398-405. PubMed ID: 18318824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoluminal gastroplication for treatment of patients with classic gastroesophageal reflux symptoms and borderline 24-h pH studies.
    Liu JJ; Carr-Locke DL; Lee LS; Brooks DC; Saltzman JR
    Scand J Gastroenterol; 2004 Jul; 39(7):615-20. PubMed ID: 15370680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.
    Miyamoto M; Manabe N; Haruma K
    Intern Med; 2010; 49(15):1469-76. PubMed ID: 20686276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan.
    Ozawa S; Kumai K; Higuchi K; Arakawa T; Kato M; Asaka M; Katada N; Kuwano H; Kitajima M
    J Gastroenterol; 2009; 44(7):675-84. PubMed ID: 19440812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors.
    Matsumura T; Sonoda M; Okimoto K; Dao HV; Takahashi S; Akizue N; Horio R; Goto C; Kurosugi A; Kaneko T; Ohta Y; Taida T; Kikuchi A; Fujie M; Kato J; Kato N
    Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
    Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
    Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of functional heartburn based on Rome III criteria in Japanese patients.
    Tamura Y; Funaki Y; Izawa S; Iida A; Yamaguchi Y; Adachi K; Ogasawara N; Sasaki M; Kaneko H; Kasugai K
    World J Gastroenterol; 2015 Apr; 21(16):5009-16. PubMed ID: 25945016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of supplemental cautery during endoluminal gastroplication for the treatment of gastroesophageal reflux disease.
    Mosler P; Aziz AM; Hieston K; Filipi C; Lehman G
    Surg Endosc; 2008 Oct; 22(10):2158-63. PubMed ID: 18629586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux.
    Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M
    Digestion; 2020; 101(2):174-183. PubMed ID: 30897577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an endoscopic suturing device (the "ESD") to treat patients with gastroesophageal reflux disease, after unsuccessful EndoCinch endoluminal gastroplication: another failure.
    Schiefke I; Neumann S; Zabel-Langhennig A; Moessner J; Caca K
    Endoscopy; 2005 Aug; 37(8):700-5. PubMed ID: 16032486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autofluorescence imaging endoscopy can distinguish non-erosive reflux disease from functional heartburn: A pilot study.
    Luo X; Guo XX; Wang WF; Peng LH; Yang YS; Uedo N
    World J Gastroenterol; 2016 Apr; 22(14):3845-51. PubMed ID: 27076770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
    Desjardin M; Luc G; Collet D; Zerbib F
    Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.